News

Morgan Stanley names KKR “top pick,” citing capital markets rebound
KKR shares have fallen 9% year-to-date, underperforming the alternative asset manager group, which is down 2%, and the S&P ...
Morgan Stanley Hikes Western Digital (WDC) Target to $78, Reaffirms Bullish View
Western Digital Corporation (NASDAQ: WDC) is one of the 20 undervalued momentum stocks that are taking off. Morgan Stanley ...
Morgan Stanley sees improved outlook for TSMC’s U.S. investment under new policy
“According to CNBC, under the latest ‘big beautiful bill’ passed by the U.S. Senate on July 1, tax credits for those ...
Intel's possible shift to 14A from 18A creates minimal near-term impact: Morgan Stanley
Intel's (NASDAQ:INTC) potential plan to shift the focus of its Foundry to a 14A process from the current 18A would have ...
MS initiates coverage on AI Biotechs, flags key pipeline catalysts
Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts ...
M.Stanley takes neutral stance on Genmab ahead of portfolio, execution updates
In sum, though Morgan Stanley views Genmab’s management execution and pipeline-building strategy as sound, it sees 2026 as a ...
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating
Rhythm Technologies, Inc. (NASDAQ:IRTC) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Morgan Stanley has raised its price target on iRhythm Technologies, Inc. (NASDAQ:IRTC ...
What could a shift in Intel’s foundry strategy bring?
Intel’s mooted plan to push key foundry work from its coming 18A manufacturing node to a later 14A process would not meaningfully affect earnings over the next two years, Morgan Stanley (NYSE:MS) said ...